Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes
Public ClinicalTrials.gov record NCT01368536. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12-week, Multi-Center, Randomized Double-Blind, Active Control Parallel Group Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes
Study identification
- NCT ID
- NCT01368536
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Enrollment
- 975 participants
Conditions and interventions
Conditions
Interventions
- Amlodipine Drug
- Chlorthalidone Drug
- Placebo Capsule Drug
- Placebo of Valturna Tablet Drug
- Valturna Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2011
- Primary completion
- Jan 31, 2012
- Completion
- Jan 31, 2012
- Last update posted
- Mar 20, 2013
2011 – 2012
United States locations
- U.S. sites
- 95
- U.S. states
- 30
- U.S. cities
- 81
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novartis Investigative Site | Athens | Alabama | 35611 | — |
| Novartis Investigative Site | Florence | Alabama | 35630 | — |
| Novartis Investigative Site | Huntsville | Alabama | 35801 | — |
| Novartis Investigative Site | Montgomery | Alabama | 36106 | — |
| Novartis Investigative Site | Muscle Shoals | Alabama | 35662 | — |
| Novartis Investigative Site | Chandler | Arizona | 85224 | — |
| Novartis Investigative Site | Little Rock | Arkansas | 72204 | — |
| Novartis Investigative Site | Buena Park | California | 90620 | — |
| Novartis Investigative Site | Fair Oaks | California | 95628 | — |
| Novartis Investigative Site | Fresno | California | 93726 | — |
| Novartis Investigative Site | Healdsburg | California | 95448 | — |
| Novartis Investigative Site | Los Angeles | California | 90057 | — |
| Novartis Investigative Site | Orangevale | California | 95662 | — |
| Novartis Investigative Site | Riverside | California | 92506 | — |
| Novartis Investigative Site | Roseville | California | 95661 | — |
| Novartis Investigative Site | Sacramento | California | 95816 | — |
| Novartis Investigative Site | Santa Ana | California | 92701 | — |
| Novartis Investigative Site | West Covina | California | 91790 | — |
| Novartis Investigative Site | Shelton | Connecticut | 06484 | — |
| Novartis Investigative Site | Fort Lauderdale | Florida | 33306 | — |
| Novartis Investigative Site | Fort Lauderdale | Florida | 33308 | — |
| Novartis Investigative Site | Jupiter | Florida | 33458 | — |
| Novartis Investigative Site | Lauderdale Lakes | Florida | 33319 | — |
| Novartis Investigative Site | North Miami Beach | Florida | 33169 | — |
| Novartis Investigative Site | St. Petersburg | Florida | 33701 | — |
| Novartis Investigative Site | Tampa | Florida | 33603 | — |
| Novartis Investigative Site | West Palm Beach | Florida | 33409 | — |
| Novartis Investigative Site | Augusta | Georgia | 30904 | — |
| Novartis Investigative Site | Honolulu | Hawaii | 96813 | — |
| Novartis Investigative Site | Chicago | Illinois | 60607 | — |
| Novartis Investigative Site | Chicago | Illinois | 60610 | — |
| Novartis Investigative Site | Chicago | Illinois | 60617 | — |
| Novartis Investigative Site | Gurnee | Illinois | 60031 | — |
| Novartis Investigative Site | Lansing | Kansas | 66043 | — |
| Novartis Investigative Site | Topeka | Kansas | 66606 | — |
| Novartis Investigative Site | Beltsville | Maine | 20705 | — |
| Novartis Investigative Site | Waltham | Massachusetts | 02453 | — |
| Novartis Investigative Site | Wellesley Hills | Massachusetts | 02481-2106 | — |
| Novartis Investigative Site | Brooklyn Center | Minnesota | 55430-2168 | — |
| Novartis Investigative Site | Belzoni | Mississippi | 39038 | — |
| Novartis Investigative Site | Jackson | Mississippi | 39209 | — |
| Novartis Investigative Site | Picayune | Mississippi | 39466 | — |
| Novartis Investigative Site | Kansas City | Missouri | 64111 | — |
| Novartis Investigative Site | Ozark | Missouri | 65721 | — |
| Novartis Investigative Site | St Louis | Missouri | 63110-1093 | — |
| Novartis Investigative Site | St Louis | Missouri | 63128 | — |
| Novartis Investigative Site | St Louis | Missouri | 63141 | — |
| Novartis Investigative Site | Omaha | Nebraska | 68134 | — |
| Novartis Investigative Site | Henderson | Nevada | 89014 | — |
| Novartis Investigative Site | Las Vegas | Nevada | 89119 | — |
| Novartis Investigative Site | Toms River | New Jersey | 08753 | — |
| Novartis Investigative Site | Toms River | New Jersey | 08755 | — |
| Novartis Investigative Site | Trenton | New Jersey | 08629 | — |
| Novartis Investigative Site | Buffalo | New York | 14209 | — |
| Novartis Investigative Site | Camillus | New York | 13031 | — |
| Novartis Investigative Site | Asheboro | North Carolina | 27204 | — |
| Novartis Investigative Site | Asheville | North Carolina | 28801 | — |
| Novartis Investigative Site | Greensboro | North Carolina | 27401 | — |
| Novartis Investigative Site | Greensboro | North Carolina | 27408 | — |
| Novartis Investigative Site | Shelby | North Carolina | 28150 | — |
| Novartis Investigative Site | Winston-Salem | North Carolina | 27103 | — |
| Novartis Investigative Site | Fargo | North Dakota | 58103 | — |
| Novartis Investigative Site | Cincinnati | Ohio | 45219 | — |
| Novartis Investigative Site | Cincinnati | Ohio | 45224 | — |
| Novartis Investigative Site | Columbus | Ohio | 43201 | — |
| Novartis Investigative Site | Lyndhurst | Ohio | 44124 | — |
| Novartis Investigative Site | Zanesville | Ohio | 43701 | — |
| Novartis Investigative Site | Oklahoma City | Oklahoma | 73132-4904 | — |
| Novartis Investigative Site | Oklahoma City | Oklahoma | 73134 | — |
| Novartis Investigative Site | Portland | Oregon | 97232 | — |
| Novartis Investigative Site | Reading | Pennsylvania | 19609 | — |
| Novartis Investigative Site | Uniontown | Pennsylvania | 15401 | — |
| Novartis Investigative Site | Wallingford | Pennsylvania | 19086 | — |
| Novartis Investigative Site | Charleston | South Carolina | 29407 | — |
| Novartis Investigative Site | Charleston | South Carolina | 29412 | — |
| Novartis Investigative Site | Easley | South Carolina | 29640 | — |
| Novartis Investigative Site | Greenville | South Carolina | 29615 | — |
| Novartis Investigative Site | Mt. Pleasant | South Carolina | 29464 | — |
| Novartis Investigative Site | Summerville | South Carolina | 29485 | — |
| Novartis Investigative Site | Varnville | South Carolina | 29944 | — |
| Novartis Investigative Site | Fayetteville | Tennessee | 33734 | — |
| Novartis Investigative Site | Arlington | Texas | 76012 | — |
| Novartis Investigative Site | Austin | Texas | 78728-6904 | — |
| Novartis Investigative Site | Austin | Texas | 78735 | — |
| Novartis Investigative Site | Dallas | Texas | 75235 | — |
| Novartis Investigative Site | Houston | Texas | 77025 | — |
| Novartis Investigative Site | Houston | Texas | 77074 | — |
| Novartis Investigative Site | Houston | Texas | 77081 | — |
| Novartis Investigative Site | Houston | Texas | 77083 | — |
| Novartis Investigative Site | Lake Jackson | Texas | 77566 | — |
| Novartis Investigative Site | Pasadena | Texas | 77504 | — |
| Novartis Investigative Site | Plano | Texas | 75093 | — |
| Novartis Investigative Site | Richardson | Texas | 75080 | — |
| Novartis Investigative Site | St. George | Utah | 84790 | — |
| Novartis Investigative Site | Arlington | Virginia | 22203 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01368536, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 20, 2013 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01368536 live on ClinicalTrials.gov.